Purple Biotech PPBT
NASDAQ PPBT
$1.52 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Purple Biotech (PPBT) Current Leases (2020 - 2026)

Updated

Purple Biotech (PPBT) reported Current Leases of $184,000 for Q1 2026, up 34.3% from $137,000 a year earlier but down 24.6% from the prior quarter.

Analysis

Purple Biotech (PPBT) Current Leases (2020 - 2026) Analysis & Trends

At the end of FY2025, Purple Biotech posted Current Leases of $244,000, up 33.3% from FY2024.

  • Current Leases has a five-year compound annual growth rate of 3.3% (FY2020 to FY2025).
  • By year, Current Leases came in at $183,000 in FY2024 (-2.7%), $188,000 in FY2023 (-3.1%), $194,000 in FY2022 (-2.5%) and $199,000 in FY2021 (-3.9%).
  • Five-year quarterly Current Leases spans a low of $137,000 in Q1 2025 and a high of $244,000 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.32 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Purple Biotech 249,214.64 191,214.64 - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 184,000.00
Dec 31, 2025 244,000.00
Mar 31, 2025 137,000.00
Dec 31, 2024 183,000.00
Dec 31, 2023 188,000.00
Dec 31, 2022 194,000.00
Dec 31, 2021 199,000.00
Dec 31, 2020 207,000.00
API Access

Purple Biotech Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=PPBT&period=max&api_key=YOUR_API_KEY